Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolomic Profile in Tear Film Before and After Cataract Surgery
NCT05433428Phase 4Unknown
- Sponsor
- Ifocus Øyeklinikk
- Start
- Aug 2020
- Primary completion
- Jan 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dexamethasone and diclofenac in dry eye disease (DED) (3 arms), sponsored by Ifocus Øyeklinikk. Primary endpoint: Metabolomic and lipodomic profile at 6 weeks. Status: unknown.
02
Drugs
dexamethasonediclofenac
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT05433428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05433428.